Christophe Douat

Founder at MEDINCELL S.A.

62 year

Consumer Services

Health Technology

Finance

Profile

Christophe Douat is the founder of MedinCell SA, serving as Chief Executive Officer & Director since 2003.
Mr. Douat is also the founder of Matignon Technologies II FCPR.
Current jobs include Chairman at Great North SARL and Director at CM Biomaterials BV.
Former jobs include Director-Stakes at Matignon Investissement et Gestion SAS from 2001 to 2010, Director at Arterial Remodelling Technologies SA, Director at Groupement International d'Informatique de Santé SA, Member-Supervisory Board at Nanobiotix SA from 2011 to 2017, Member-Supervisory Board at Nanobiotix SA from 2006 to 2009, General Manager at Sabourin Lake Lodge from 1992 to 1997, and Venture Partner at Matignon Technologies from 2001 to 2009.
Education includes a graduate degree from the University of Minnesota, an MBA from the University of Calgary, and an undergraduate degree from École Nationale Supérieure des Mines de Paris.

Christophe Douat active positions

Companies	Position	Start
MEDINCELL S.A.	Founder	08/01/2003
Great North SARL	Chairman	-
CM Biomaterials BV CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic products	Director/Board Member	-

All active positions of Christophe Douat

Former positions of Christophe Douat

Companies	Position	End
NANOBIOTIX	Director/Board Member	31/12/2016
Matignon Investissement et Gestion SAS Matignon Investissement et Gestion SAS Investment ManagersFinance MIG is an active private equity investment manager with a long-term outlook. Originally investing across a variety of industries, the firm has progressively focused on sectors including medical technology, healthcare-related services and biotechnology. They also invest in the information and communication technology sector, and their expansion financing and LBO activities are not sector-specific. MIG acquires significant minority stakes in French, European and US companies, balancing their investments across development stages. The firm targets companies based on a coherent commercial strategy and whose research efforts are mature. They seek board representation. Their exit strategies favor trade sales to large biomedical groups. MIG's specific interests within their sectors of expertise have included orthopedic implants for spinal surgery, nutritional counseling, biodegradable cardiovascular stents, surgical navigation systems, glucose measurement, sleep apnea and HIV non-progression.	Private Equity Investor	30/04/2010
Matignon Technologies	Corporate Officer/Principal	31/03/2009
NANOBIOTIX	Director/Board Member	31/12/2008
Sabourin Lake Lodge	Corporate Officer/Principal	31/12/1996

See the detail of Christophe Douat's experience

Training of Christophe Douat

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christophe Douat's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Matignon Investissement et Gestion SAS Matignon Investissement et Gestion SAS Investment ManagersFinance MIG is an active private equity investment manager with a long-term outlook. Originally investing across a variety of industries, the firm has progressively focused on sectors including medical technology, healthcare-related services and biotechnology. They also invest in the information and communication technology sector, and their expansion financing and LBO activities are not sector-specific. MIG acquires significant minority stakes in French, European and US companies, balancing their investments across development stages. The firm targets companies based on a coherent commercial strategy and whose research efforts are mature. They seek board representation. Their exit strategies favor trade sales to large biomedical groups. MIG's specific interests within their sectors of expertise have included orthopedic implants for spinal surgery, nutritional counseling, biodegradable cardiovascular stents, surgical navigation systems, glucose measurement, sleep apnea and HIV non-progression.	Finance
University of Minnesota University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Calgary University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
École Nationale Supérieure des Mines de Paris École Nationale Supérieure des Mines de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Matignon Technologies II FCPR Matignon Technologies II FCPR Investment ManagersFinance Acts as Venture Capital Fund	Finance
Arterial Remodelling Technologies SA Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Develops bioresorbable peripheral and coronary polymer stents	Health Technology
Nanobiotix SA Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer	Health Technology
Groupement International d'Informatique de Santé SA Groupement International d'Informatique de Santé SA Publishing: Books/MagazinesConsumer Services Engages in the management of an online health and nutrition portal	Consumer Services
MedinCell SA MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions	Health Technology
Great North SARL
CM Biomaterials BV CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic products	Producer Manufacturing
Sabourin Lake Lodge
Matignon Technologies